GLP-1 drugs are set to dominate 2024, with projected annual sales nearing $50 billion
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials
What the Evidence Actually Shows The efficacy signal for semaglutide in weight management is unusually strong for pharmacology, and it is worth being precise about what kind of evidence it is
One of the more unusual parts of the conversation is her discussion of stored iron
The 68-week, randomized, double-blind trial enrolled 445 adults with obesity or overweight and knee osteoarthritis
This article will explore the chemistry of glutathione, why its peptide structure matters, and how to ensure your body actually absorbs it